COVID-19 Treatment: The Race Against Time
Author:
Publisher
Modestum Publishing Ltd
Subject
General Medicine
Link
https://www.ejgm.co.uk/download/covid-19-treatment-the-race-against-time-7890.pdf
Reference19 articles.
1. Aljofan M, Gaipov A. Chloroquine and COVID-19: A Light at the End of the Tunnel, or is it Another Train?. Electron J Gen Med. 2020;17(4):em207. https://doi.org/10.29333/ejgm/7863
2. Zhao H, Wald J, Palmer M, Han Y. Hydroxychloroquine-induced cardiomyopathy and heart failure in twins. Journal of thoracic disease. 2018;10(1):E70. https://doi.org/10.21037/JTD.2017.12.66 PMID:29600108 PMCID:PMC5863196
3. Zeldin RK, Petruschke RA. Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. Journal of antimicrobial chemotherapy. 2004;53(1):4-9. https://doi.org/10.1093/jac/dkh029 PMID:14657084
4. Chu C, Cheng V, Hung I, Wong M, Chan K, Chan K, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252-6. https://doi.org/10.1136/thorax.2003.012658 PMID:14985565 PMCID:PMC1746980
5. Park S, Lee J, Son J, Ko J, Peck K, Jung Y, et al. Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers. Journal of Hospital Infection. 2019;101(1):42-6. https://doi.org/10.1016/j.jhin.2018.09.005 PMID:30240813 PMCID:PMC7114948
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Elucidating the Drug Repurposing Spectra of COVID-19 with its Analogues SARS and MERS;Mini-Reviews in Medicinal Chemistry;2021-12
2. Education in Online Environment from Students’ and Teachers’ Perspective;International Journal of Cognitive Research in Science Engineering and Education;2021-08-31
3. Combating the progression of novel coronavirus SARS-CoV-2 infectious Disease: Current state and future prospects in molecular diagnostic and drug discovery;Current Molecular Medicine;2021-08-03
4. An Insight into Pandemic COVID-19: Structure, Epidemiology and Therapeutics;Current Biotechnology;2021-05-20
5. Review of pharmacologic and immunologic agents in the management of COVID-19;Biosafety and Health;2021-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3